title: Editorial comment--an approach to the estimation of the risk of TTP during clopidogrel therapy.
authors.forename: Saran
authors.initials: S
authors.lastname: Jonas
authors.forename: Giacinto
authors.initials: G
authors.lastname: Grieco
mesh_terms: D000077144:Clopidogrel; D004363:Drug Utilization / Q000706:statistics & numerical data; D006801:Humans; D015994:Incidence; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D011358:Product Surveillance, Postmarketing / Q000706:statistics & numerical data; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced* / Q000453:epidemiology; D018570:Risk Assessment; D013988:Ticlopidine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D014481:United States / Q000453:epidemiology
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine